Does the media favor AHCO or HIMS?

In the previous week, Hims & Hers Health had 20 more articles in the media than AdaptHealth. MarketBeat recorded 23 mentions for Hims & Hers Health and 3 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 1.78 beat Hims & Hers Health's score of 0.84 indicating that AdaptHealth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdaptHealth 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Hims & Hers Health 7 Very Positive mention(s) 8 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AHCO or SHC?

In the previous week, AdaptHealth had 1 more articles in the media than Sotera Health. MarketBeat recorded 3 mentions for AdaptHealth and 2 mentions for Sotera Health. AdaptHealth's average media sentiment score of 1.78 beat Sotera Health's score of 1.15 indicating that AdaptHealth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdaptHealth 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Sotera Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AHCO or CAI?

In the previous week, Caris Life Sciences had 1 more articles in the media than AdaptHealth. MarketBeat recorded 4 mentions for Caris Life Sciences and 3 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 1.78 beat Caris Life Sciences' score of 0.40 indicating that AdaptHealth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdaptHealth 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Caris Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Is RDNT or AHCO more profitable?

RadNet has a net margin of -0.66% compared to AdaptHealth's net margin of -2.42%. RadNet's return on equity of 2.77% beat AdaptHealth's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% AdaptHealth -2.42% 2.76% 0.99%

Does the media refer more to RDNT or AHCO?

In the previous week, RadNet had 2 more articles in the media than AdaptHealth. MarketBeat recorded 5 mentions for RadNet and 3 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 1.78 beat RadNet's score of 0.31 indicating that AdaptHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AdaptHealth 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer AHCO or BLLN?

In the previous week, AdaptHealth and AdaptHealth both had 3 articles in the media. AdaptHealth's average media sentiment score of 1.78 beat Billiontoone's score of 1.09 indicating that AdaptHealth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdaptHealth 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Billiontoone 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

AdaptHealth (AHCO) Competitors

$9.72 +0.08 (+0.78%)

Closing price 03:58 PM Eastern

Extended Trading

$9.74 +0.02 (+0.15%)

As of 04:23 PM Eastern

Compare

AHCO vs. HIMS, SHC, CAI, RDNT, and BLLN

Should you buy AdaptHealth stock or one of its competitors? MarketBeat compares AdaptHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AdaptHealth include Hims & Hers Health (HIMS), Sotera Health (SHC), Caris Life Sciences (CAI), RadNet (RDNT), and Billiontoone (BLLN). These companies are all part of the "healthcare" industry.

How does AdaptHealth compare to Hims & Hers Health?

AdaptHealth (NASDAQ:AHCO) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

AdaptHealth has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, meaning that its stock price is 137% more volatile than the broader market.

Hims & Hers Health has lower revenue, but higher earnings than AdaptHealth. Hims & Hers Health is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.24B	0.41	-$70.79M	-$0.62	N/A
Hims & Hers Health	$2.35B	2.71	$128.37M	-$0.09	N/A

AdaptHealth currently has a consensus price target of $14.29, suggesting a potential upside of 46.90%. Hims & Hers Health has a consensus price target of $28.70, suggesting a potential upside of 4.40%. Given AdaptHealth's stronger consensus rating and higher probable upside, research analysts plainly believe AdaptHealth is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 2.0% of AdaptHealth shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Hims & Hers Health has a net margin of -0.56% compared to AdaptHealth's net margin of -2.42%. Hims & Hers Health's return on equity of 6.10% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-2.42%	2.76%	0.99%
Hims & Hers Health	-0.56%	6.10%	1.52%

In the previous week, Hims & Hers Health had 20 more articles in the media than AdaptHealth. MarketBeat recorded 23 mentions for Hims & Hers Health and 3 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 1.78 beat Hims & Hers Health's score of 0.84 indicating that AdaptHealth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdaptHealth	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Hims & Hers Health	7 Very Positive mention(s)	8 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Hims & Hers Health beats AdaptHealth on 9 of the 16 factors compared between the two stocks.

How does AdaptHealth compare to Sotera Health?

AdaptHealth (NASDAQ:AHCO) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 2.0% of AdaptHealth shares are held by company insiders. Comparatively, 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

AdaptHealth has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market.

AdaptHealth currently has a consensus price target of $14.29, suggesting a potential upside of 46.90%. Sotera Health has a consensus price target of $20.33, suggesting a potential upside of 33.16%. Given AdaptHealth's higher probable upside, research analysts plainly believe AdaptHealth is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70

Sotera Health has a net margin of 9.91% compared to AdaptHealth's net margin of -2.42%. Sotera Health's return on equity of 39.73% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-2.42%	2.76%	0.99%
Sotera Health	9.91%	39.73%	7.05%

In the previous week, AdaptHealth had 1 more articles in the media than Sotera Health. MarketBeat recorded 3 mentions for AdaptHealth and 2 mentions for Sotera Health. AdaptHealth's average media sentiment score of 1.78 beat Sotera Health's score of 1.15 indicating that AdaptHealth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdaptHealth	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Sotera Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sotera Health has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.24B	0.41	-$70.79M	-$0.62	N/A
Sotera Health	$1.16B	3.74	$77.94M	$0.41	37.24

Summary

Sotera Health beats AdaptHealth on 12 of the 16 factors compared between the two stocks.

How does AdaptHealth compare to Caris Life Sciences?

AdaptHealth (NASDAQ:AHCO) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

82.7% of AdaptHealth shares are held by institutional investors. 2.0% of AdaptHealth shares are held by insiders. Comparatively, 50.0% of Caris Life Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Caris Life Sciences has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.24B	0.41	-$70.79M	-$0.62	N/A
Caris Life Sciences	$812.03M	5.39	-$68.09M	-$7.61	N/A

AdaptHealth currently has a consensus price target of $14.29, indicating a potential upside of 46.90%. Caris Life Sciences has a consensus price target of $27.56, indicating a potential upside of 78.01%. Given Caris Life Sciences' higher probable upside, analysts plainly believe Caris Life Sciences is more favorable than AdaptHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

Caris Life Sciences has a net margin of 3.75% compared to AdaptHealth's net margin of -2.42%. Caris Life Sciences' return on equity of 98.28% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-2.42%	2.76%	0.99%
Caris Life Sciences	3.75%	98.28%	48.87%

In the previous week, Caris Life Sciences had 1 more articles in the media than AdaptHealth. MarketBeat recorded 4 mentions for Caris Life Sciences and 3 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 1.78 beat Caris Life Sciences' score of 0.40 indicating that AdaptHealth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdaptHealth	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Caris Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Caris Life Sciences beats AdaptHealth on 10 of the 15 factors compared between the two stocks.

How does AdaptHealth compare to RadNet?

RadNet (NASDAQ:RDNT) and AdaptHealth (NASDAQ:AHCO) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

RadNet has a net margin of -0.66% compared to AdaptHealth's net margin of -2.42%. RadNet's return on equity of 2.77% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
AdaptHealth	-2.42%	2.76%	0.99%

In the previous week, RadNet had 2 more articles in the media than AdaptHealth. MarketBeat recorded 5 mentions for RadNet and 3 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 1.78 beat RadNet's score of 0.31 indicating that AdaptHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AdaptHealth	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

RadNet has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.47, meaning that its share price is 47% more volatile than the broader market.

RadNet presently has a consensus price target of $87.43, indicating a potential upside of 68.55%. AdaptHealth has a consensus price target of $14.29, indicating a potential upside of 46.90%. Given RadNet's stronger consensus rating and higher possible upside, research analysts plainly believe RadNet is more favorable than AdaptHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

RadNet has higher earnings, but lower revenue than AdaptHealth. RadNet is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.00	-$18.65M	-$0.18	N/A
AdaptHealth	$3.24B	0.41	-$70.79M	-$0.62	N/A

77.9% of RadNet shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Comparatively, 2.0% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

RadNet beats AdaptHealth on 11 of the 17 factors compared between the two stocks.

How does AdaptHealth compare to Billiontoone?

AdaptHealth (NASDAQ:AHCO) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

In the previous week, AdaptHealth and AdaptHealth both had 3 articles in the media. AdaptHealth's average media sentiment score of 1.78 beat Billiontoone's score of 1.09 indicating that AdaptHealth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdaptHealth	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Billiontoone	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Billiontoone has a net margin of 0.00% compared to AdaptHealth's net margin of -2.42%. AdaptHealth's return on equity of 2.76% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-2.42%	2.76%	0.99%
Billiontoone	N/A	N/A	N/A

82.7% of AdaptHealth shares are owned by institutional investors. 2.0% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Billiontoone has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.24B	0.41	-$70.79M	-$0.62	N/A
Billiontoone	$305.11M	14.83	$7.45M	$0.55	178.84

AdaptHealth currently has a consensus target price of $14.29, indicating a potential upside of 46.90%. Billiontoone has a consensus target price of $125.29, indicating a potential upside of 27.37%. Given AdaptHealth's higher probable upside, equities analysts clearly believe AdaptHealth is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

AdaptHealth beats Billiontoone on 7 of the 13 factors compared between the two stocks.

Get AdaptHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AHCO vs. The Competition

Export

Metric	AdaptHealth	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.31B	$8.16B	$6.47B	$12.54B
Dividend Yield	N/A	2.61%	2.69%	5.22%
P/E Ratio	-15.69	15.39	22.39	24.18
Price / Sales	0.41	7.06	520.79	112.26
Price / Cash	2.30	17.10	41.34	57.13
Price / Book	0.86	3.53	9.84	6.72
Net Income	-$70.79M	$224.05M	$3.57B	$337.19M
7 Day Performance	-6.13%	-1.09%	-1.16%	0.48%
1 Month Performance	-26.16%	0.34%	3.85%	5.07%
1 Year Performance	9.76%	-0.29%	27.40%	34.25%

AdaptHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AHCO AdaptHealth	4.984 of 5 stars	$9.73 +0.8%	$14.29 +46.9%	+10.3%	$1.31B	$3.24B	N/A	10,900	Positive News Insider Trade
HIMS Hims & Hers Health	2.9216 of 5 stars	$23.71 -0.2%	$28.90 +21.9%	-51.4%	$5.41B	$2.35B	N/A	2,442	Trending News
SHC Sotera Health	3.7611 of 5 stars	$15.66 flat	$20.33 +29.8%	+23.2%	$4.47B	$1.16B	38.20	3,000
CAI Caris Life Sciences	4.7619 of 5 stars	$15.55 flat	$27.56 +77.2%	N/A	$4.40B	$812.03M	N/A	1,846	Analyst Downgrade Gap Down
RDNT RadNet	3.7811 of 5 stars	$54.40 flat	$87.43 +60.7%	-6.8%	$4.28B	$2.04B	N/A	11,264

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AHCO) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AdaptHealth (AHCO) Competitors

AHCO vs. HIMS, SHC, CAI, RDNT, and BLLN

How does AdaptHealth compare to Hims & Hers Health?

Summary

How does AdaptHealth compare to Sotera Health?

Summary

How does AdaptHealth compare to Caris Life Sciences?

Summary

How does AdaptHealth compare to RadNet?

Summary

How does AdaptHealth compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AHCO vs. The Competition

AdaptHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AdaptHealth (AHCO) Competitors

AHCO vs. HIMS, SHC, CAI, RDNT, and BLLN

How does AdaptHealth compare to Hims & Hers Health?

Which has more risk and volatility, AHCO or HIMS?

Which has preferable earnings and valuation, AHCO or HIMS?

Do analysts prefer AHCO or HIMS?

Do institutionals and insiders hold more shares of AHCO or HIMS?

Is AHCO or HIMS more profitable?

Does the media favor AHCO or HIMS?

Summary

How does AdaptHealth compare to Sotera Health?

Do institutionals & insiders hold more shares of AHCO or SHC?

Which has more risk and volatility, AHCO or SHC?

Do analysts rate AHCO or SHC?

Is AHCO or SHC more profitable?

Does the media prefer AHCO or SHC?

Which has preferable valuation & earnings, AHCO or SHC?

Summary

How does AdaptHealth compare to Caris Life Sciences?

Do institutionals & insiders believe in AHCO or CAI?

Which has better earnings and valuation, AHCO or CAI?

Do analysts prefer AHCO or CAI?

Is AHCO or CAI more profitable?

Does the media refer more to AHCO or CAI?

Summary

How does AdaptHealth compare to RadNet?

Is RDNT or AHCO more profitable?

Does the media refer more to RDNT or AHCO?

Which has more volatility & risk, RDNT or AHCO?

Do analysts recommend RDNT or AHCO?

Which has stronger valuation and earnings, RDNT or AHCO?

Do insiders and institutionals have more ownership in RDNT or AHCO?

Summary

How does AdaptHealth compare to Billiontoone?

Does the media prefer AHCO or BLLN?

Is AHCO or BLLN more profitable?

Do insiders & institutionals believe in AHCO or BLLN?

Which has higher valuation & earnings, AHCO or BLLN?

Do analysts rate AHCO or BLLN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AHCO vs. The Competition

AdaptHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools